Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bayer’s Nexavar May Have Prolonged Life in Some Lung Patients
Bloomberg
Saturday, September 29, 2012 - 11:57am
tags:
Nexavar, Bayer, lung cancer
Glaxo Two-Drug Melanoma Combo Slows Cancer in Study
Bloomberg
Saturday, September 29, 2012 - 11:55am
tags:
GSK, melanoma, dabrafenib, trametinib
Pomerantz Law Firm Has Filed a Class Action Against Peregrine Pharmaceuticals, Inc. -- PPHM
Yahoo/GlobeNewsWire
Saturday, September 29, 2012 - 11:53am
tags:
Peregrine Pharmaceuticals, lawsuits
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Questcor Pharmaceuticals, Inc.
Yahoo/BusinessWire
Saturday, September 29, 2012 - 11:51am
tags:
Questcor Pharmaceuticals, lawsuits
Is Novo Nordisk the Perfect Stock?
Motley Fool
Saturday, September 29, 2012 - 11:51am
tags:
Novo Nordisk
Twin Orphan Drug News
Motley Fool
Saturday, September 29, 2012 - 11:50am
tags:
Biomarin, orphan drugs, Peg-Pal, phenylketonuria, Kuvan
A Home Run Drug in the Holy Land
Motley Fool
Saturday, September 29, 2012 - 11:48am
tags:
Elelyso, Gaucher disease, Protalix BioTherapeutics
Novo Nordisk halts development of hemophilia drug
Reuters
Friday, September 28, 2012 - 12:11pm
tags:
Novo Nordisk, hemophilia, vatreptacog alfa, NovoSeven
Cell Therapeutics: European Revenue Opportunity Could Represent A Turning Point
Seeking Alpha
Friday, September 28, 2012 - 12:02pm
tags:
Cell Therapeutics, Europe, Pixuvri, non-Hodgkin B-cell lymphoma
Trading Merck Ahead of the Patent Cliff
Motley Fool
Friday, September 28, 2012 - 11:40am
tags:
Merck, patent cliff, Pfizer, Lipitor, Singulair, Plavix, Bristol-Myers Squibb
Watson Pharma selling $3.75B in senior notes to help fund Actavis deal
Bloomberg Businessweek
Friday, September 28, 2012 - 11:08am
tags:
Watson Pharmaceuticals, Actavis, M&A
Roche should pick up AbbVie or BMS, analyst thinks
Fierce Pharma
Friday, September 28, 2012 - 10:49am
tags:
AbbVie, Roche, Bristol-Myers Squibb, M&A
Illumina Aims at Roche for Tests Seen Worth $25 Billion
Bloomberg
Friday, September 28, 2012 - 10:47am
tags:
Roche, Illumina, DNA sequencing
Cytori’s Stem Cell Therapy for Burns Wins U.S. Contract
Bloomberg
Friday, September 28, 2012 - 10:45am
tags:
stem cells, Cytori, burns
Teva Pharma acquires rights to Huntexil for $26M
Yahoo/AP
Friday, September 28, 2012 - 10:35am
tags:
Teva Pharmaceuticals, Huntexil, Huntington's disease, Neurosearch
Glaxo, Cipla Seen as Biggest Losers as India Sets Prices
Bloomberg
Friday, September 28, 2012 - 10:24am
tags:
GSK, Cipla, India
A.P. Pharma Resubmits New Drug Application for APF530, a Product Candidate for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Yahoo
Friday, September 28, 2012 - 10:22am
tags:
AP Pharma, APF530, chemotherapy-induced nausea and vomiting
VEN-307 is Ideal for a Small Company to Launch, says Ventrus CEO
Yahoo/Reuters
Friday, September 28, 2012 - 10:20am
tags:
Ventrus, VEN-307, anal fissures
5 Low Risk, High Reward Biotech Stocks
Motley Fool
Friday, September 28, 2012 - 10:19am
tags:
Arena Pharmaceuticals, Aeterna Zentaris, Incyte, Jazz Pharmaceuticals, Astex
[video] The Next Big Thing in Biotech: Hepatitis Drugs
TheStreet.com
Friday, September 28, 2012 - 10:18am
tags:
hepatitis C, Abbott Labs, Gilead Sciences, JNJ, Merck, Vertex Pharmaceuticals, Idenix, Achillion

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.